Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1).
Fractalkine (CX3CL1) is an unusual member of the chemokine family that is synthesized with its chemokine domain at the end of a mucin-rich, transmembrane stalk. This membrane-bound localization allows fractalkine to function as an adhesion molecule for cells bearing its receptor, CX3CR1. In addition...
Main Authors: | Garton, K, Gough, P, Blobel, C, Murphy, G, Greaves, D, Dempsey, P, Raines, E |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2001
|
Similar Items
-
Fractalkine/CX3CL1 in Neoplastic Processes
by: Jan Korbecki, et al.
Published: (2020-05-01) -
Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1).
by: Lucas, A, et al.
Published: (2003) -
The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo.
by: Lucas, A, et al.
Published: (2001) -
Fractalkine (CX3CL1), a new factor protecting β-cells against TNFα
by: Sabine Rutti, et al.
Published: (2014-10-01) -
Fractalkine/CX3CL1 engages different neuroprotective responses upon selective glutamate receptor overactivation.
by: Clotilde eLauro, et al.
Published: (2015-01-01)